Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 4 studies | 29% ± 10% |
Insufficient scRNA-seq data for expression of SLC13A2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 98% | 1975.30 | 87 / 89 | 30% | 5.00 | 272 / 901 |
intestine | 49% | 2848.95 | 477 / 966 | 60% | 8.80 | 315 / 527 |
breast | 53% | 366.10 | 242 / 459 | 54% | 6.24 | 599 / 1118 |
skin | 62% | 470.77 | 1114 / 1809 | 2% | 0.08 | 8 / 472 |
stomach | 0% | 1.19 | 1 / 359 | 62% | 10.75 | 178 / 286 |
liver | 16% | 15.81 | 36 / 226 | 44% | 8.15 | 178 / 406 |
pancreas | 2% | 3.96 | 6 / 328 | 47% | 5.92 | 83 / 178 |
esophagus | 1% | 4.16 | 21 / 1445 | 24% | 3.90 | 44 / 183 |
lung | 2% | 3.29 | 12 / 578 | 20% | 3.72 | 235 / 1155 |
bladder | 0% | 0 | 0 / 21 | 21% | 2.95 | 108 / 504 |
ovary | 1% | 0.69 | 1 / 180 | 20% | 2.15 | 87 / 430 |
thymus | 0% | 0.16 | 1 / 653 | 14% | 0.69 | 87 / 605 |
uterus | 1% | 0.65 | 1 / 170 | 12% | 1.46 | 53 / 459 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.57 | 4 / 45 |
adrenal gland | 0% | 1.75 | 1 / 258 | 7% | 0.22 | 16 / 230 |
prostate | 2% | 13.85 | 4 / 245 | 4% | 0.16 | 21 / 502 |
adipose | 2% | 12.17 | 27 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
muscle | 0% | 0.56 | 4 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.35 | 3 / 1335 | 0% | 0 | 0 / 0 |
brain | 0% | 0.04 | 1 / 2642 | 0% | 0.05 | 1 / 705 |
heart | 0% | 0.21 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071422 | Biological process | succinate transmembrane transport |
GO_0015742 | Biological process | alpha-ketoglutarate transport |
GO_0015741 | Biological process | fumarate transport |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0071285 | Biological process | cellular response to lithium ion |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0015139 | Molecular function | alpha-ketoglutarate transmembrane transporter activity |
GO_0015361 | Molecular function | low-affinity sodium:dicarboxylate symporter activity |
GO_0015141 | Molecular function | succinate transmembrane transporter activity |
GO_0015138 | Molecular function | fumarate transmembrane transporter activity |
GO_0017153 | Molecular function | sodium:dicarboxylate symporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC13A2 |
Protein name | SLC13A2 protein Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter) Solute carrier family 13 (Sodium-dependent dicarboxylate transporter), member 2 Solute carrier family 13 member 2 |
Synonyms | SDCT1 NADC1 |
Description | FUNCTION: Low-affinity sodium-dicarboxylate cotransporter, that mediates the entry of citric acid cycle intermediates, such as succinate, citrate, fumarate and alpha-ketoglutarate (2-oxoglutarate) into the small intestine and renal proximal tubule . Transports the dicarboxylate into the cell with a probable stoichiometry of 3 Na(+) for 1 divalent dicarboxylate, rendering the process electrogenic . Citrate is transported in protonated form as a divalent anion, rather than the trivalent form which is normally found in blood . Has a critical role in renal dicarboxylate transport (By similarity). . |
Accessions | Q4VAR9 ENST00000579281.5 J3QR70 ENST00000314669.10 [Q13183-1] ENST00000459818.2 Q8IV67 ENST00000444914.7 [Q13183-3] Q13183 J3QL78 |